A citation-based method for searching scientific literature

Samira Abbasi, Ataollah Abbasi, Yashar Sarbaz. Comput Methods Programs Biomed 2014
Times Cited: 4







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Taiji Tsunemi, Kinya Ishikawa, Kei Tsukui, Takuro Sumi, Ken Kitamura, Hidehiro Mizusawa. J Neurol Sci 2010
20
50

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
112
50

Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
K Wessel, J Hermsdörfer, K Deger, T Herzog, G P Huss, D Kömpf, N Mai, K Schimrigk, A Wittkämper, W Ziegler. Arch Neurol 1995
44
25

Cerebellar ataxia: pathophysiology and rehabilitation.
Jon Marsden, Chris Harris. Clin Rehabil 2011
53
25

Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up.
Mercè Pineda, Javier Arpa, Raquel Montero, Asunción Aracil, Francisco Domínguez, Marta Galván, Anna Mas, Loreto Martorell, Cristina Sierra, Nuria Brandi,[...]. Eur J Paediatr Neurol 2008
73
25

Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
I Sobue, T Takayanagi, T Nakanishi, T Tsubaki, M Uono, M Kinoshita, A Igata, M Miyazaki, M Yoshida, K Ando. J Neurol Sci 1983
77
25

Action of physostigmine on inherited ataxias.
M M Rodriguez-Budelli, R A Kark, J P Blass, M A Spence. Adv Neurol 1978
10
25

Milestones in ataxia.
Thomas Klockgether, Henry Paulson. Mov Disord 2011
52
25

Effectiveness and safety of treatments for degenerative ataxias: a systematic review.
M Mar Trujillo-Martín, Pedro Serrano-Aguilar, Fernando Monton-Alvarez, Romen Carrillo-Fumero. Mov Disord 2009
40
25

Dietary treatment of gluten ataxia.
M Hadjivassiliou, G A B Davies-Jones, D S Sanders, R A Grünewald. J Neurol Neurosurg Psychiatry 2003
129
25





Sensory neuron diseases.
Angelo Sghirlanzoni, Davide Pareyson, Giuseppe Lauria. Lancet Neurol 2005
112
25

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
941
25

Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study.
J C Bier, S Dethy, J Hildebrand, J Jacquy, M Manto, J-J Martin, P Seeldrayers. J Neurol 2003
19
25

Treatment of spinocerebellar ataxia with buspirone.
Mitra Assadi, Joseph V Campellone, Christopher G Janson, J Jon Veloski, Robert J Schwartzman, Paola Leone. J Neurol Sci 2007
20
25

Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.
M I Botez, T Botez-Marquard, R Elie, O L Pedraza, K Goyette, R Lalonde. J Neurol Neurosurg Psychiatry 1996
61
25

Use of buspirone for treatment of cerebellar ataxia. An open-label study.
J S Lou, L Goldfarb, L McShane, P Gatev, M Hallett. Arch Neurol 1995
66
25

Diagnosis and management of early- and late-onset cerebellar ataxia.
E Brusse, J A Maat-Kievit, J C van Swieten. Clin Genet 2007
69
25

Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.
G P Rice, J Lesaux, P Vandervoort, L Macewan, G C Ebers. J Neurol Neurosurg Psychiatry 1997
56
25

Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials.
Jonas Alex Morales Saute, Karina Carvalho Donis, Carmen Serrano-Munuera, David Genis, Luís Torres Ramirez, Pilar Mazzetti, Luis Velázquez Pérez, Pilar Latorre, Jorge Sequeiros, Antoni Matilla-Dueñas,[...]. Cerebellum 2012
74
25

The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia.
A Filla, G De Michele, F Cavalcanti, L Pianese, A Monticelli, G Campanella, S Cocozza. Am J Hum Genet 1996
383
25

Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole.
Ying-Jun Cao, John C Dreixler, Jonathan J Couey, Khaled M Houamed. Eur J Pharmacol 2002
88
25


Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Y S Piao, S Hayashi, M Hasegawa, K Wakabayashi, M Yamada, M Yoshimoto, A Ishikawa, T Iwatsubo, H Takahashi. Acta Neuropathol 2001
61
25


Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
Nicholas A Di Prospero, Angela Baker, Neal Jeffries, Kenneth H Fischbeck. Lancet Neurol 2007
189
25

Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
I Sobue, H Yamamoto, M Konagaya, M Iida, T Takayanagi. Lancet 1980
90
25


Neurodegeneration in ataxia telangiectasia: what is new? What is evident?
Franziska Hoche, Kay Seidel, Marius Theis, Stefan Vlaho, Ralf Schubert, Stefan Zielen, Matthias Kieslich. Neuropediatrics 2012
49
25

Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
101
25

An approach to the patient with late-onset cerebellar ataxia.
Brent L Fogel, Susan Perlman. Nat Clin Pract Neurol 2006
35
25


Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
Asako Takei, Toshiyuki Fukazawa, Takeshi Hamada, Hiroyuki Sohma, Ichiro Yabe, Hidenao Sasaki, Kunio Tashiro. Clin Neuropharmacol 2004
24
25

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
890
25


Intensive coordinative training improves motor performance in degenerative cerebellar disease.
W Ilg, M Synofzik, D Brötz, S Burkard, M A Giese, L Schöls. Neurology 2009
143
25

Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.
K Wessel, K Langenberger, M F Nitschke, D Kömpf. Arch Neurol 1997
21
25

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
T A Zesiewicz, P E Greenstein, K L Sullivan, L Wecker, A Miller, I Jahan, R Chen, S L Perlman. Neurology 2012
68
25

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.
S H Subramony, W May, D Lynch, C Gomez, K Fischbeck, M Hallett, P Taylor, R Wilson, T Ashizawa. Neurology 2005
202
25

Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study.
Asako Takei, Shinsuke Hamada, Sanae Homma, Keiko Hamada, Kunio Tashiro, Takeshi Hamada. Cerebellum 2010
15
25


Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
G K Wenning, Y Ben Shlomo, M Magalhães, S E Daniel, N P Quinn. Brain 1994
597
25

Therapeutic interventions in the primary hereditary ataxias.
Gonzalo J Revuelta, George R Wilmot. Curr Treat Options Neurol 2010
4
25

Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry.
I Yabe, H Sasaki, I Yamashita, A Takei, K Tashiro. Acta Neurol Scand 2001
45
25

Pathophysiology of cerebellar ataxia.
H C Diener, J Dichgans. Mov Disord 1992
144
25

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.
Ichiro Miyai, Mizuki Ito, Noriaki Hattori, Masahito Mihara, Megumi Hatakenaka, Hajime Yagura, Gen Sobue, Masatoyo Nishizawa. Neurorehabil Neural Repair 2012
94
25

The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.
Jae-Hyeok Heo, Soon-Tae Lee, Kon Chu, Manho Kim. J Neurol Sci 2008
18
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.